Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date

1 Quality of life and self-esteem in children treated for idiopathic short stature
article 2002    
Author: Theunissen, N.C.M. · Kamp, G.A. · Koopman, H.M. · Zwinderman, K.A.H. · Vogels, T. · Wit, J.-M.
Keywords: Human growth hormone · Body growth · Body height · Child · Clinical article · Clinical trial · Controlled clinical trial · Controlled study · Hormonal therapy · Idiopathic disease · Multicenter study · Patient satisfaction · Quality of life · Questionnaire · Randomized controlled trial · Self concept · Self esteem · Short stature · Social adaptation · social status · Analysis of Variance · Body Height · Child · Child, Preschool · Female · Growth Hormone · Humans · Linear Models · Male · Netherlands · Prospective Studies · Quality of Life · Self Concept
[Abstract]

2 Inhibitors and activation markers of the haemostatic system during hormone therapy: A comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone
article 2008    
Author: Norris, L.A. · Brosnan, J. · Bonnar, J. · Conard, J. · Kluft, C. · Hellgren, M.
Keywords: Health · Haemostasis · Hormones · Venous thrombosis · Activated protein C · Antiplasmin · Antithrombin · Blood clotting factor 5 Leiden · Dydrogesterone plus estradiol · Estradiol plus trimegestone · Estrogen derivative · Plasmin · Protein S · Prothrombin · Adult · Aged · Clinical trial · Controlled clinical trial · Controlled study · Double blind procedure · Drug effect · Drug inhibition · Female · Fibrinolysis · Gene mutation · Hormonal therapy · Human · Medical assessment · Multicenter study · Multiple cycle treatment · Postmenopause · Protein blood level · Protein function · Randomized controlled trial · Administration, Oral · Estrogen Replacement Therapy · Factor V · Hemostasis · Humans · Middle Aged · Progestins · Promegestone · Protein C · Protein S · Risk Factors · Venous Thrombosis
[Abstract]

3 Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review
article 2008    
Author: Hemelaar, M. · Mooren, M.J. van der · Rad, M. · Kluft, C. · Kenemans, P.
Keywords: Biology · cardiovascular disease · intranasal · Postmenopausal hormone therapy · risk factors · transdermal · venous thromboembolism · activated protein C · antithrombin · blood clotting factor 7 · C reactive protein · cell adhesion molecule · chlormadinone acetate · conjugated estrogen · cyproterone acetate plus estradiol valerate · dydrogesterone · dydrogesterone plus estradiol · endothelin 1 · estradiol · estradiol valerate · estrone sulfate · gestodene · homocysteine · hormone · lipoprotein · medrogestone · medroxyprogesterone acetate · n(g),n(g) dimethylarginine · nomegestrol acetate · norethisterone acetate · placebo · progesterone · protein C · protein S · prothrombin · article · atherosclerosis · blood clotting · cardiovascular risk · clinical trial · drug effect · drug mechanism · endothelial dysfunction · fibrinolysis · follow up · hormonal therapy · human · inflammation · ischemic heart disease · outcome assessment · postmenopause · priority journal · systematic review · venous thromboembolism · Administration, Oral · Atherosclerosis · Biological Markers · Estrogen Replacement Therapy · Estrogens · Female · Humans · Incidence · Risk Assessment · Risk Factors · Venous Thrombosis
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date